Opportunities in the Medullary Thyroid Cancer market arise from diverse pipeline developments by 8+ companies. Focus areas include novel therapies like Regorafenib and next-gen RET inhibitors ...

Eli Lilly launches Tanstrive, a targeted oral cancer therapy for RET-altered tumors, priced at ₹2.15 lakh for two weeks.

Tanstrive is available in India in tablet strengths of 40 mg, 80 mg, 120 mg, and 160 mg. The treatment is administered twice ...

New Delhi, Jun 25 (PTI) Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India.The launch follows marketing authorisation from the Central Drugs ...

Eli Lilly and Company India Pvt Ltd announced the launch of Tanstrive (selpercatinib) in India, following marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for ...

Eli Lilly (NYSE:LLY) has once again captured the attention of the oncology community after reporting remarkably strong Phase 3 results for Retevmo (selpercatinib) in early-stage RET fusion-positive ...

Former US Capitol riot prosecutors, fired federal officials and journalists who say they were past targets of President Donald Trump’s retribution tell CNN they may seek compensation from the Justice ...

Steve is a Guides Contributor at GameRant. He discovered a passion for video games with the original Sonic the Hedgehog game on the Sega Genesis. His love deepened with the original Pokémon Red and ...

The International Long COVID Awareness Day, observed on March 15, served as a reminder that long COVID is often unrecognized by physicians and remains understudied. The #AprèsJ20 Association COVID ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Lizzy leads STAT’s coverage of the FDA. Her ...

It is designed to selectively target RET alterations and block the abnormal signalling pathways that drive tumour growth.